Home

Aurobindo Pharma PE Ratio

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

PE

19

Last updated on: Oct 17, 2025

Key Highlights

  • The P/E Ratio of Aurobindo Pharma Ltd is 19 as of 17 Oct 15:30 PM .
  • The P/E Ratio of Aurobindo Pharma Ltd changed from 8.5 on March 2020 to 19.3 on March 2025 . This represents a CAGR of 14.65% over 6 years.
  • The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1101 as of 17 Oct 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.2 to 39.7 in 5 years. This represents a CAGR of 13.37%.
  • The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 19.1. The PE Ratio of IT - Software industry is 27.7. The PE Ratio of Pharmaceuticals industry is 32.6. The PE Ratio of Retail industry is 124.0. The PE Ratio of Textiles industry is 54.8 in 2025.

Historical P/E Ratio of Aurobindo Pharma Ltd

No data available

Company Fundamentals for Aurobindo Pharma Ltd

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

Share Price

₹ 1101.45

-4.30 (-0.39%)

stock direction

Last updated on: Oct 17, 2025

Market Price of Aurobindo Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Oct 20251101.45
16 Oct 20251105.75
15 Oct 20251109.25
14 Oct 20251123.45
13 Oct 20251136.75
10 Oct 20251130.6
09 Oct 20251118.95
08 Oct 20251069.85
07 Oct 20251089.75
06 Oct 20251096.15

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Aurobindo Pharma Ltd

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Aurobindo Pharma Ltd64538
Sun Pharmaceutical Industries Ltd402872
Divis Laboratories Ltd175706
Cipla Ltd127449
Torrent Pharmaceuticals Ltd121119
Dr Reddys Laboratories Ltd104827

PE Ratio of Aurobindo Pharma Ltd Explained

64538

Market cap

3391

Earnings

19.0X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Aurobindo Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Aurobindo Pharma Ltd

No data available

* All values are in %

About Aurobindo Pharma Ltd

  • Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
  • Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
  • APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
  • The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
  • APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

Aurobindo Pharma Ltd News Hub

Lyfius Pharma re-starts production at its Penicillin-G manufacturing facility

Aurobindo Pharma announced that its wholly owned step-down subsidiary, Lyfius Pharma has restarted t

Read more

30 Jun 25

Aurobindo Pharma Ltd down for fifth straight session

Aurobindo Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs 1109.7,

Read more

17 Jun 25

Aurobindo Pharma gets UK MHRA approval for neutropenia treatment drug Dyrupeg

Dyrupeg contains the active substance pegfilgrastim and is a biological medicine. It is a 'biosimila

Read more

25 Jun 25

Aurobindo Pharma's US arm incorporates Cresedemo Pharma in U.S.

The purpose of incorporating this new entity is to expand the company's pharmaceutical products busi

Read more

16 Jun 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Aurobindo Pharma Ltd

What is the current PE Ratio of Aurobindo Pharma Ltd?

The Current PE Ratio of Aurobindo Pharma Ltd is 19.03 as on 17 Oct 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 32.6 as on 17 Oct 2025.

What was the PE Ratio of Aurobindo Pharma Ltd last year?

The PE Ratio of Aurobindo Pharma Ltd was 20.12 last year, now the PE ratio is 19.03, showing a year-on-year growth of -5.4%.

What does the PE Ratio of Aurobindo Pharma Ltd indicate about its stock?

The PE Ratio of Aurobindo Pharma Ltd is 19.03. This ratio indicates that investors are willing to pay 19.03 times the earnings per share for each share of Aurobindo Pharma Ltd.

What is the PE Ratio Growth of Aurobindo Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Aurobindo Pharma Ltd grew by -5.4% whereas, the EPS ratio grew by -8.7.

How does the PE ratio of Aurobindo Pharma Ltd compare to industry peers?

The PE ratio of Aurobindo Pharma Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Aurobindo Pharma Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Aurobindo Pharma Ltd PE Ratio.

What factors influence the PE ratio of Aurobindo Pharma Ltd PE Ratio?

The PE ratio of Aurobindo Pharma Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Aurobindo Pharma Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Aurobindo Pharma Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Aurobindo Pharma Ltd PE Ratio?

You can check the latest PE ratio of Aurobindo Pharma Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Aurobindo Pharma Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Aurobindo Pharma Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Aurobindo Pharma Ltd PE Ratio predict future stock performance?

While the Aurobindo Pharma Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions